• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 时代的急性肝衰竭和慢加急性肝衰竭

Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era.

作者信息

Kanda Tatsuo, Sasaki-Tanaka Reina, Ishii Tomotaka, Abe Hayato, Ogawa Masahiro, Enomoto Hirayuki

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.

Department of Digestive Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.

出版信息

J Clin Med. 2022 Jul 21;11(14):4249. doi: 10.3390/jcm11144249.

DOI:10.3390/jcm11144249
PMID:35888013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9316387/
Abstract

Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF), respectively, occur in patients with normal liver and patients with chronic liver diseases, including cirrhosis [...].

摘要

急性肝衰竭（ALF）和慢加急性肝衰竭（ACLF）分别发生在肝脏正常的患者以及患有慢性肝病（包括肝硬化）的患者中[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fe/9316387/a9938f457a79/jcm-11-04249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fe/9316387/a9938f457a79/jcm-11-04249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fe/9316387/a9938f457a79/jcm-11-04249-g001.jpg

相似文献

1
Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era.COVID-19 时代的急性肝衰竭和慢加急性肝衰竭
J Clin Med. 2022 Jul 21;11(14):4249. doi: 10.3390/jcm11144249.
2
Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure.威尔逊病患者急性肝衰竭与慢加急性肝衰竭的长期预后比较。
J Med Assoc Thai. 2013 Feb;96(2):150-6.
3
Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.COVID-19 相关慢加急性肝衰竭的危险因素和结局：一项大型多中心观察性队列研究。
Hepatol Int. 2021 Jun;15(3):766-779. doi: 10.1007/s12072-021-10181-y. Epub 2021 Apr 7.
4
Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children.儿童急性肝衰竭（ALF）和慢性肝病急性肝衰竭（ACLF）的多器官受累情况及重症监护病房（ICU）护理考量
Transl Pediatr. 2021 Oct;10(10):2749-2762. doi: 10.21037/tp-20-375.
5
[Acute Liver Failure, Acute-On-Chronic Liver Failure, Hepatorenal Syndrome, Hepatopulmonary Syndrome and Portopulmonary Hypertension, Artificial Liver Support on the ICU].[急性肝衰竭、慢加急性肝衰竭、肝肾综合征、肝肺综合征和门肺高压，重症监护病房的人工肝支持]
Zentralbl Chir. 2017 Jun;142(3):275-286. doi: 10.1055/s-0043-106198. Epub 2017 Jun 22.
6
Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure.急性肝衰竭时肝内皮细胞的功能丧失与肝实质细胞再生不良相关。
Hepatol Int. 2019 Nov;13(6):777-787. doi: 10.1007/s12072-019-09983-y. Epub 2019 Sep 12.
7
Two-tier regenerative response in liver failure in humans.人类肝功能衰竭中的双层再生反应。
Virchows Arch. 2014 May;464(5):565-73. doi: 10.1007/s00428-014-1547-0. Epub 2014 Mar 4.
8
Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: A single-center retrospective study.标准量血浆置换治疗急性和慢性急性肝衰竭的预后因素及治疗效果：一项单中心回顾性研究。
Transfus Apher Sci. 2018 Aug;57(4):537-543. doi: 10.1016/j.transci.2018.05.030. Epub 2018 Jun 2.
9
Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review.血浆置换治疗急性和慢加急性肝衰竭患者的系统评价。
World J Gastroenterol. 2020 Jan 14;26(2):219-245. doi: 10.3748/wjg.v26.i2.219.
10
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.Toll 样受体 4 是防治肝衰竭的治疗靶点。
J Hepatol. 2020 Jul;73(1):102-112. doi: 10.1016/j.jhep.2020.01.011. Epub 2020 Jan 24.

引用本文的文献

1
Liver Damage and COVID-19: At Least a "Two-Hit" Story in Systematic Review.肝损伤与新冠病毒病：系统评价中至少是一个“双重打击”的故事
Curr Issues Mol Biol. 2023 Apr 4;45(4):3035-3047. doi: 10.3390/cimb45040199.
2
Outcomes of COVID-19 among patients with liver disease.COVID-19 患者的肝病结局。
World J Gastroenterol. 2023 Feb 7;29(5):815-824. doi: 10.3748/wjg.v29.i5.815.

本文引用的文献

1
COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.直接作用抗病毒药物治疗 HCV 感染和失代偿性肝硬化后 COVID-19：病例报告。
In Vivo. 2022 Jul-Aug;36(4):1986-1993. doi: 10.21873/invivo.12923.
2
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line.辉瑞生物科技公司新冠mRNA疫苗BNT162b2在人肝细胞系中的体外细胞内逆转录
Curr Issues Mol Biol. 2022 Feb 25;44(3):1115-1126. doi: 10.3390/cimb44030073.
3
Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.
基于分子对接技术评价潜在抗甲型肝炎病毒 3C 蛋白酶抑制剂。
Int J Mol Sci. 2022 May 27;23(11):6044. doi: 10.3390/ijms23116044.
4
Epidemiology of liver failure in Asia-Pacific region.亚太地区肝衰竭的流行病学。
Liver Int. 2022 Aug;42(9):2093-2109. doi: 10.1111/liv.15328. Epub 2022 Jun 10.
5
Single-Cell RNA Transcriptomics Reveals the State of Hepatic Lymphatic Endothelial Cells in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.单细胞RNA转录组学揭示乙型肝炎病毒相关慢加急性肝衰竭中肝淋巴管内皮细胞的状态
J Clin Med. 2022 May 20;11(10):2910. doi: 10.3390/jcm11102910.
6
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF).高级器官支持（ADVOS）对慢加急性肝衰竭（ACLF）患者细胞因子水平的影响。
J Clin Med. 2022 May 15;11(10):2782. doi: 10.3390/jcm11102782.
7
COVID-19 and Autoimmune Liver Diseases.新型冠状病毒肺炎与自身免疫性肝病
J Clin Med. 2022 May 10;11(10):2681. doi: 10.3390/jcm11102681.
8
Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan.日本急性慢性肝衰竭及相关疾病状态的诊断标准。
Hepatol Res. 2022 May;52(5):417-421. doi: 10.1111/hepr.13763.
9
The recent outbreak of acute severe hepatitis in children of unknown origin - what is known so far.近期不明来源儿童急性重症肝炎爆发 - 目前已知情况。
J Hepatol. 2022 Jul;77(1):237-242. doi: 10.1016/j.jhep.2022.05.001. Epub 2022 May 6.
10
Indicator of Inflammation and NETosis-Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis.炎症和中性粒细胞胞外诱捕网形成指标——低密度粒细胞作为自身免疫性肝炎的生物标志物
J Clin Med. 2022 Apr 13;11(8):2174. doi: 10.3390/jcm11082174.